Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2/3 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Head & Neck 1Gynecologic 1Dermatologic 1Breast 1

Conditions

Virus Diseases 2Urinary Bladder Neoplasms 2Melanoma 2Lung Neoplasms 2Head and Neck Neoplasms 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Sarcoma 1Ovarian Neoplasms 1Neoplasms 1Kidney Neoplasms 1Gastrointestinal Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma in Situ 1Carcinoma 1Brain Neoplasms 1Adenoviridae Infections 1

Interventions

Gemcitabine 157Cisplatin 117pembrolizumab 82Cystectomy 46Nivolumab 42Carboplatin 42Paclitaxel 41Mitomycin 41Docetaxel 39atezolizumab 33Magnetic Resonance Spectroscopy 33Radiotherapy 31durvalumab 30avelumab 26BCG Vaccine 26Specimen Handling 25enfortumab vedotin 24Cystoscopy 24Doxorubicin 23Fluorouracil 20Methotrexate 17Vinblastine 16Standard of Care 15Ipilimumab 14Filgrastim 145-aminolevulinic acid hexyl ester 14Transurethral Resection of Bladder 13Surgical Procedures, Operative 13Sunitinib 13Biopsy 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × Oncolytic Virotherapy × Genitourinary × Clear all
NCT05180851 2022-02-01

YSCH-01

Shanghai Fengxian District Central Hospital

Phase EARLY_PHASE1 Unknown
28 enrolled
BreastDermatologicGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Virus Diseases

NCT01438112 2021-04-14

BOND

CG Oncology, Inc.

Phase 2/3 Terminated
22 enrolled
Genitourinary

Adenoviridae Infections, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell, Neoplasms, Virus Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡